Kanagawa, Japan

Takeo Harada

This inventor holds 1 USPTO granted patent. Top assignees: Nippon Steel Chemical Co., Ltd., Nippon Steel Corporation. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeo Harada. Retrieved from https://idiyas.com/inventor/takeo-harada-azdn2ev2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Takeo Harada

Introduction

Takeo Harada is a notable inventor hailing from Kanagawa, Japan. His work focuses on advancements in pharmaceuticals, particularly in the realm of receptor antagonists. Harada's innovative contributions are evidenced by his patent that demonstrates his commitment to enhancing medical treatments.

Latest Patents

Harada holds a patent for a fibrinogen receptor antagonist and pharmaceutical compositions. This patent includes compounds of a general formula (I) and pharmaceutically acceptable salts thereof, showcasing his expertise in developing new therapeutic strategies.

Career Highlights

Throughout his career, Takeo Harada has made significant strides in the pharmaceutical industry. He has been associated with notable companies such as Nippon Steel Corporation and Nippon Steel Chemical Co., Ltd. His work at these respected institutions has allowed him to contribute meaningfully to the field of medicinal chemistry.

Collaborations

In his journey as an inventor, Harada has collaborated with esteemed colleagues, including Yoshio Hayashi and Jun Katada. These partnerships have been instrumental in his research endeavors and have enriched his contributions to the scientific community.

Conclusion

Takeo Harada's work exemplifies innovation in pharmaceutical research and development. With his valuable patent and collaborations, he continues to impact the industry positively. His commitment to advancing medical science through inventions makes him a prominent figure in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…